These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 18979140

  • 1. Breast cancer risk factors in younger and older women.
    Chun J, Pocock B, Joseph KA, El-Tamer M, Klein L, Schnabel F.
    Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
    [Abstract] [Full Text] [Related]

  • 2. Predictors of breast cancer development in a high-risk population.
    Chun J, El-Tamer M, Joseph KA, Ditkoff BA, Schnabel F.
    Am J Surg; 2006 Oct; 192(4):474-7. PubMed ID: 16978952
    [Abstract] [Full Text] [Related]

  • 3. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.
    Cancer; 2006 Jan 01; 106(1):42-50. PubMed ID: 16333852
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R, Carolin K, Wallis T, Visscher DW.
    Hum Pathol; 2003 Mar 01; 34(3):234-9. PubMed ID: 12673557
    [Abstract] [Full Text] [Related]

  • 5. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY, Ren GS, Arnould N, Brettes JP.
    Zhonghua Wai Ke Za Zhi; 2007 Jul 01; 45(13):874-6. PubMed ID: 17953828
    [Abstract] [Full Text] [Related]

  • 6. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 7. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
    Margenthaler JA, Duke D, Monsees BS, Barton PT, Clark C, Dietz JR.
    Am J Surg; 2006 Oct 15; 192(4):534-7. PubMed ID: 16978969
    [Abstract] [Full Text] [Related]

  • 8. Lobular neoplasia on core needle biopsy does not require excision.
    Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM.
    Cancer; 2008 May 15; 112(10):2152-8. PubMed ID: 18348299
    [Abstract] [Full Text] [Related]

  • 9. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA, Mrose HE, Ioffe OB.
    Radiology; 2001 Feb 15; 218(2):503-9. PubMed ID: 11161169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cohort study of women at risk for breast cancer and gross cystic disease.
    Chun J, Joseph KA, El-Tamer M, Rundle A, Jacobson J, Schnabel F.
    Am J Surg; 2005 Oct 15; 190(4):583-7. PubMed ID: 16164926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER, Park A, Borgen PI, Morris E, Montgomery LL.
    Ann Surg Oncol; 2007 Mar 15; 14(3):1051-7. PubMed ID: 17206485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P, Naccarato AG, Bocci G, Fanelli G, Aretini P, Lonobile A, Evangelista G, Montruccoli G, Bevilacqua G.
    J Pathol; 2004 Oct 15; 204(2):140-6. PubMed ID: 15376259
    [Abstract] [Full Text] [Related]

  • 17. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
    Isern AE, Loman N, Malina J, Olsson H, Ringberg A.
    Eur J Surg Oncol; 2008 Oct 15; 34(10):1148-54. PubMed ID: 18434071
    [Abstract] [Full Text] [Related]

  • 18. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
    Fabian CJ, Zalles C, Kamel S, Zeiger S, Simon C, Kimler BF.
    J Cell Biochem Suppl; 1997 Oct 15; 28-29():101-10. PubMed ID: 9589354
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.